Grewal Rajan, Sklar Michael C, de Almeida John R, Xu Wei, Su Jie, Thomas Carissa M, Alibhai Shabbir M H, Goldstein David P
Department of Otolaryngology Head and Neck Surgery/Surgical Oncology University Health Network, Princess Margaret Cancer Center, University of Toronto Toronto Ontario Canada.
Interdepartmental Division of Critical Care Medicine University of Toronto Toronto Ontario Canada.
Laryngoscope Investig Otolaryngol. 2020 Dec 9;6(1):103-108. doi: 10.1002/lio2.491. eCollection 2021 Feb.
Being able to predict negative postoperative outcomes is important for helping select patients for treatment as well for informed decision-making by patients. Frailty measures are often time and resource intensive to use as screening measures, whereas the Braden scale, a commonly used measure to assess patients at risk of developing pressure ulcers after surgery, may be a potential tool to predict postoperative complication rates and longer length of stay (LOS) in patients undergoing major head and neck cancer surgery.
A retrospective analysis of Braden scale scores was performed on a prospectively collected cohort of patients undergoing major head and neck surgery recruited between December 2011 and April 2014. The association of Braden scale score with the primary outcomes of complications and LOS was analyzed using logistic regression and linear regression models on univariate analysis (UVA), respectively. Multivariate analysis (MVA) was performed based on a backward stepwise selection algorithm.
There were 232 patients with a mean (SD) Braden scale score of 14.9 (2.8) with a range from 9 to 23. The Braden scale (β = -.07 per point; 95% CI -0.09, -0.04, < .001) was an independent predictor of increased LOS on UVA, but not on MVA when adjusted for other variables. For overall complications, as well as type of complication, the Braden scale score was not a significant predictor of complications on either UVA or MVA.
In the sample population, the Braden scale did not demonstrate an ability to predict negative outcomes in head and neck surgery patients.
Level 2b individual cohort study.
能够预测术后不良结局对于帮助选择治疗患者以及患者做出明智决策非常重要。虚弱测量作为筛查措施通常需要大量时间和资源,而Braden量表是一种常用的评估术后有发生压疮风险患者的工具,它可能是预测接受重大头颈癌手术患者术后并发症发生率和更长住院时间的潜在工具。
对2011年12月至2014年4月前瞻性收集的接受重大头颈手术患者队列进行Braden量表评分的回顾性分析。分别使用逻辑回归和线性回归模型对Braden量表评分与并发症和住院时间的主要结局之间的关联进行单变量分析(UVA)。基于向后逐步选择算法进行多变量分析(MVA)。
共有232例患者,Braden量表平均(标准差)评分为14.9(2.8),范围为9至23。在UVA上,Braden量表(每分β=-0.07;95%可信区间-0.09,-0.04,P<0.001)是住院时间延长的独立预测因素,但在调整其他变量后,在MVA上不是。对于总体并发症以及并发症类型,Braden量表评分在UVA或MVA上均不是并发症的显著预测因素。
在样本人群中,Braden量表未显示出预测头颈手术患者不良结局的能力。
2b级个体队列研究。